Sponsor hub

University of Florida clinical trial failures

Review 65 stopped clinical trials from University of Florida, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 1 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials65
Likely biological signals1
Shown below65

Dominant stop reasons

OPERATIONAL
38
OTHER/UNKNOWN
24
REGULATORY
2
EFFICACY/FUTILITY
1

Notable sponsors

University of Florida
65

Related phases

Phase II
21
Phase I
19
Phase IV
14
Early Phase I
4
Phase III
4

Crawlable stopped-trial records

Open Explore

Showing up to 65 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT03736343: Impulsivity and Alcohol Response

Early Phase I Alcohol Use Disorder (AUD) trial by University of Florida. Stop reason: OPERATIONAL.

The COVID-19 outbreak began, precluding further participant recruitment for this protocol, which could only be conducted in-person. A decision was made that ample data was available to end data collection earlier than anticipated.

NCT02069431: Oxytocin Aging Study

Phase I Inflammation trial by University of Florida. Stop reason: OPERATIONAL.

This study was halted prematurely due to the COVID-19 pandemic, resulting in the inability to enroll participants. Funding for this project has also ended.